HEDROS Biotechnology
About HEDROS Biotechnology
PhagePro develops bacteriophage-based therapies to combat bacterial infections, offering a targeted approach to disease control. Their platform provides highly selective agents that infect and destroy specific bacteria, paving the way for new antibacterial treatments.
PhagePro develops bacteriophage-based therapies to combat bacterial infections, offering a targeted approach to disease control. Their platform provides highly selective agents that infect and destroy specific bacteria, paving the way for new antibacterial treatments.
What does HEDROS Biotechnology do?
PhagePro develops bacteriophage-based therapies to combat bacterial infections, offering a targeted approach to disease control. Their platform provides highly selective agents that infect and destroy specific bacteria, paving the way for new antibacterial treatments.
Where is HEDROS Biotechnology located?
HEDROS Biotechnology is based in United States.
- Location
- United States
- Employees
- 6 employees